Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure

Stephen Zicha1, María Fernández-Velasco, Giuseppe Lonardo

  • 1Department of Medicine and Research Center, Montreal Heart Institute and University of Montreal, Quebec, Canada.

Insights

Congestive heart failure (CHF) downregulates key hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the sinus node, impairing pacemaker function. Upregulated HCN4 in the atria may promote arrhythmias.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Cardiac Electrophysiology

Background:

  • The hyperpolarization-activated cation current I(f) is crucial for heart pacemaker function.
  • Expression patterns of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel subunits in normal and diseased hearts are not well understood.
  • Congestive heart failure (CHF) is associated with cardiac rhythm disturbances.

Purpose of the Study:

  • To investigate the expression of HCN1, HCN2, and HCN4 channel subunits in normal canine hearts.
  • To determine how CHF affects HCN subunit expression in the sinoatrial node and right atrium.
  • To elucidate the molecular basis of CHF-induced sinus node dysfunction and potential arrhythmia formation.

Main Methods:

  • Assessed HCN1, HCN2, and HCN4 mRNA and protein expression using competitive RT-PCR, Western blot, and immunohistochemistry.
  • Studied normal mongrel dogs and dogs with 2-week ventricular tachypacing-induced CHF.
  • Quantified expression in the sinoatrial node and right atrium.

Main Results:

  • HCN4 was the dominant subunit, followed by HCN2, with minimal HCN1 expression in normal hearts.
  • Sinoatrial node HCN2 and HCN4 expression was significantly decreased in CHF at both mRNA and protein levels.
  • Right atrial HCN4 expression was significantly upregulated in CHF, while HCN2 remained unchanged.

Conclusions:

  • HCN4 is the predominant subunit in the canine sinoatrial node and right atrium.
  • Downregulation of HCN2 and HCN4 in the sinus node contributes to CHF-induced pacemaker dysfunction.
  • Upregulation of atrial HCN4 may play a role in promoting atrial arrhythmias in CHF.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...